Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialisation Clinician and caregiver global efficacy measures showed a level of improvement typically considered clinically meaningful: – Clinical Global Impression of Improvement (CGI-I) – […]